Sulfonamide allergy and cross-reactivity

Current Allergy and Asthma Reports

Volumn 7, Issue 1, 2007, Pages 41-48

  Brackett, Carolyn C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ACETOHEXAMIDE; AMPRENAVIR; ANTIBIOTIC AGENT; AROMATIC AMINE; BENZOCAINE; CELECOXIB; COTRIMOXAZOLE; DAPSONE; DRUG METABOLITE; IBUTILIDE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LOOP DIURETIC AGENT; NIMESULIDE; PENICILLIN G; PROBENECID; PROCAINAMIDE; ROFECOXIB; SOTALOL; SULFAMETHOXAZOLE; SULFONAMIDE; SULFONYLUREA; THIAZIDE DIURETIC AGENT; TRIPTAN DERIVATIVE; ZONISAMIDE;

ANAPHYLAXIS; ASEPTIC MENINGITIS; BLOOD DYSCRASIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS ALLERGY; CROSS REACTION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; ECZEMA; FIXED DRUG ERUPTION; GASTROINTESTINAL SYMPTOM; HUMAN; HUMORAL IMMUNITY; HYPOGLYCEMIA; IMMUNOPATHOGENESIS; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE ACIDOSIS; LIVER TOXICITY; LOW DRUG DOSE; MACULOPAPULAR RASH; MAJOR HISTOCOMPATIBILITY COMPLEX; MYOCARDITIS; PENICILLIN ALLERGY; PNEUMONIA; POLYARTHRITIS; REVIEW; SERUM SICKNESS; SINGLE DRUG DOSE; STEVENS JOHNSON SYNDROME; STRUCTURE ACTIVITY RELATION; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VESICULAR RASH;

CROSS REACTIONS; DRUG HYPERSENSITIVITY; HUMANS; SULFONAMIDES;

EID: 34247477166     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0029-8     Document Type: Review

References (33)

1. Tilles S: Practical issues in the management of hypersensitivity reactions: sulfonamides. South Med J 2001, 94:817-824.
2. Kucera C, Greenberger P: Adverse drug reactions: treatment and prevention. Hosp Med 1996, 32:11-24.
3. Sullivan TJ, Ong RC, Gilliam LK: Studies of the multiple drug allergy syndrome. J Allergy Clin Immunol 1989, 83:270.
4. Patterson R, Bello AE, Lefkowith J: Immunologic tolerability profile of celecoxib. Clin Ther 1999, 21:2065-2079.
5. Alfirevic A, Stalford AC, Viklar FJ, et al.: Slow acetylator phenotype and genotype in HIV-positive patients with sulfamethoxazole hypersensitivity. Br J Clin Pharmacol 2003, 55:158-165.
6. Bukhalo M, Zeitouni NC, Cheney RT. Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylurea. Cutis 2003, 3:235-238.
7. Klinder KP, Harbilas JW, Johns TE: Drug-induced hematologic disorders. In Pharmacotherapy: A Pathophysiologic Approach, edn 5. Edited by Dipiro J, et al.. New York: McGraw-Hill; 2002:1783-1795.
8. Kuby J, ed: Hypersensitivity reactions in immunology. In Immunology, edn 3. Philadelphia: W.H. Freeman and Co.; 1997:413-439.
9. Leyva L, Torres MJ, Posadas S, et al.: Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J Allergy Clin Immunol 2000, 105:157-165.
10. Fritsch PO, Sidoroff A: Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 2000, 1:349-360.
11. Cribb AE, Lee B, Trepanier L, Spielberg SP: Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 1996, 15:9-10.
12. Roychowdhury S, Svensson CK: Mechanisms of drug-induced delayed type hypersensitivity reactions in the skin. AAPS J 2005, 7:E834-E846.
13. Kano Y, Inaoka M, Sakuma K, Shiohara T: Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology 2005, 209:165-167.
14. Hashimoto K, Yasukawa M, Tohyama M: Human herpes-virus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003, 3:255-260.
15. Harle DG, Baldo BA,Wells JV: Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole. Mol Immunol 1988, 25:1347-1354.
16. Knowles S, Shapiro L, Shear N: Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of "sulfa" allergy. Drug Saf 2001, 24:239-247.
17. Carrington DM, Earl HS, Sullivan TJ: Studies of human IgE to a sulfonamide determinant. J Allergy Clin Immunol 1987, 79:442-447.
18. Hansbrough JR, Wedner HJ, Chaplin DD: Anaphylaxis to intravenous furosemide. J Allergy Clin Immunol 1987, 80:538-541.
19. Verdel BM, Souverein PC, Egberts AC, Leafkens HG: Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure. Ann Pharmacother 2006, 40:1040-1046.
20. Ernst EJ, Egge JA: Celecoxib-induced erythema multiforme with glyburide cross-reactivity. Pharmacotherapy 2002, 22:637-640.
21. Curtis BR, Mcfarland JG, Wu GG, et al.: Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 1994, 84:176-183.
22. Bedard K, Smith S, Cribb A: Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction. Br J Dermatol 2000, 142:253-258.
23. Gruchalla RS: Diagnosis of allergic reactions to sulfonamides. Allergy 1999, 54:28-32.
24. Friedmann PS, Lee MS, Friedmann AC, Barnetson RS: Mechanisms in cutaneous drug hypersensitivity reactions. Clin Exp Allergy 2003, 33:861-872.
25. Hess DA, Sisson ME, Suria H, et al.: Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole. FASEB J 1999, 13:1688-1698.
26. Gruchalla RS, Pesenko RD, Do TT, Skiest DJ: Sulfonamide-induced reactions in desensitized patients with AIDS - the role of covalent protein haptenation by sulfamethoxazole. J Allergy Clin Immunol 1998, 101:371-378.
27. Wulferink M, Dierkes S, Gleichmann E: Cross-sensitization to haptens: formation of common haptenic metabolites, T cell recognition of cryptic peptides, and true T cell cross-reactivity. Eur J Immunol 2002, 32:1338-1348.
28. Farrell J, Naisbitt DJ, Drummond NS, et al.: Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animal and humans. J Pharmacol Exp Ther 2003, 306:229-237.
29. + T cells from allergic individuals. J Immunol 2000, 164:6647-6654.
30. Kaur C, Sarkar R, Kanwar A: Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides [letter]. Dermatology 2001, 203:351.
31. Sarkar R, Kaur C, Kanwar A: Extensive fixed drug eruption to nimesulide with cross-sensitivity to sulfonamides in a child. Pediatr Dermatol 2002, 6:553-554.
32. Nassif A, Bensussan A, Boumsell L, et al.: Toxic epidermal necrolysis: effector cells are drug-specific crototoxic T cells. J Allergy Clin Immunol 2004, 114:1209-1215.
33. Johnson KK, Green DL, Rife JP, Limon L: Sulfonamide cross-reactivity: fact or fiction? Ann Pharmacother 2005, 39:290-301.